All Type of News
Il-Yang Pharmaceutical, “Wonbi-D exceeded KRW 30 billion sales in China last year”Il-Yang Pharmaceutical’s ‘Wonbi-D’ continues its rapid growth as recording more than KRW 30 sales in China.
According to the company, the ‘Wonbi-D’ sales have been increased ev...
|
Approvals for OTC medicines keep dropping
It was analyzed the number of approvals(registrations) for OTC medicine has continuously decreased since 2014.
According to the Ministry of Food and Drug Safety, the number of ETC medicines approved(registered) last ...
GreenCross MS supplies hemodialysis solutions of KRW 90 billion to Boryung Pharm
GreenCross Medical Science(CEO Young-Pil Kim, GreenCross MS) announced on the 19th it signed a long-term supply agreement of supplying hemodialysis solutions for 10 years with Boryung Pharm(CEO Tae-Hong Choi).
GreenC...
“The government must control illegal sales of OTC medicines at supermarkets and local stores”
The Korean Pharmaceutical Association(Chairman Chan-Hwi Cho, KPA) released an written statement to take term measures against illegal sales of pharmaceutical products at supermarkets and local stores.
A number of sup...
MFDS designates products similar to teeth whitening as quasi drug
Products that are similar to teeth whitening kits will be controlled by being designated by the government as quasi drug.
The Ministry of Food and Drug Safety(MFDS) made a partial revision to the ‘Notification of the...
Janssen files patent infringement trial against Samsung BioepisJanssen, a U.S. global pharmaceutical company, filed a patent infringement trial against Samsung Bioepis.
Janssen recently sued Samsung Bioepis for infringing the 3 patents of ...
|
9 of 24 new drugs approved last year was antibiotic neoplastic agent
It was observed there were 24 pharmaceutical products approved as new drug in Korea, and 9 of them were anticancer drugs.
In the recently-published ‘2016 Drug Approval Report,’ the Ministry of Food and Drug Safety an...
Bukwang Pharm acquires joint license of Meditoxin Inj for treatment purpose from EisaiBukwang Pharm announced that it signed a co-marketing and distribution agreement with Eisai Korea for the co-sales and exclusive distribution license of ‘Meditoxin Inj 200 Units...
|
Celltrion’s active launching process for Truxima, starting to sell in GermanyCelltrion announced on the 18th that it has started to prepare for an official launch of ‘Truxima,’ the first antibody biosimilar for the treatment of blood cancer, even in Germ...
|
Female CEOs’ ‘Outstanding performance’ in management, marketing and R&D at listed pharmas
Although the female executive ratio is only 7% in listed pharmaceutical companies, they are evaluated to have outstanding performance with their active activities.
According to the Yakup Shinmoon’s(www.yakup.com) ana...
